Skip to content

Clinical trials

Phase 2 Colitis, Ulcerative trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colitis, Ulcerative Phase: Phase 2 Country / region: Serbia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20164
20173
20182
20194
20202
20213
20221
20231
20245
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated10
Active, not recruiting5
Recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abivax S.A.3
Genentech, Inc.3
Eli Lilly and Company2
Lycera Corp.2
Pfizer2
Shire2
Spyre Therapeutics, Inc.2
AbbVie1
AnaptysBio, Inc.1
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative32
Inflammatory Bowel Diseases10
Colitis6
Gastrointestinal Diseases4
Colonic Diseases2
Digestive System Diseases2
Intestinal Diseases2
Abdominal Pain1
Autoimmune Diseases1
Crohn Disease1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.